[Ecogenetic aspects of acute side effects caused by angiotensin converting enzyme inhibitors].
Angiotensin converting enzyme inhibitors are currently used in the treatment of different cardiovascular diseases. Acute side effects of acei have been attributed to bradykinin. We have evidenced a decrease catabolism of des-arg9-bradykinin in the plasma of patients who presented such side effects. This anomaly is associated with a decreased activity of plasma aminopeptidase p which is, at least partially, of genetic origin.